203 related articles for article (PubMed ID: 36693840)
1. Alterations of cohesin complex genes in acute myeloid leukemia: differential co-mutations, clinical presentation and impact on outcome.
Eckardt JN; Stasik S; Röllig C; Sauer T; Scholl S; Hochhaus A; Crysandt M; Brümmendorf TH; Naumann R; Steffen B; Kunzmann V; Einsele H; Schaich M; Burchert A; Neubauer A; Schäfer-Eckart K; Schliemann C; Krause SW; Herbst R; Hänel M; Hanoun M; Kaiser U; Kaufmann M; Rácil Z; Mayer J; Cerqueira T; Kroschinsky F; Berdel WE; Serve H; Müller-Tidow C; Platzbecker U; Baldus CD; Schetelig J; Siepmann T; Bornhäuser M; Middeke JM; Thiede C
Blood Cancer J; 2023 Jan; 13(1):18. PubMed ID: 36693840
[TBL] [Abstract][Full Text] [Related]
2. Coexisting and cooperating mutations in NPM1-mutated acute myeloid leukemia.
Patel JL; Schumacher JA; Frizzell K; Sorrells S; Shen W; Clayton A; Jattani R; Kelley TW
Leuk Res; 2017 May; 56():7-12. PubMed ID: 28152414
[TBL] [Abstract][Full Text] [Related]
3. Mutations in the cohesin complex in acute myeloid leukemia: clinical and prognostic implications.
Thol F; Bollin R; Gehlhaar M; Walter C; Dugas M; Suchanek KJ; Kirchner A; Huang L; Chaturvedi A; Wichmann M; Wiehlmann L; Shahswar R; Damm F; Göhring G; Schlegelberger B; Schlenk R; Döhner K; Döhner H; Krauter J; Ganser A; Heuser M
Blood; 2014 Feb; 123(6):914-20. PubMed ID: 24335498
[TBL] [Abstract][Full Text] [Related]
4. Genetic alterations of the cohesin complex genes in myeloid malignancies.
Thota S; Viny AD; Makishima H; Spitzer B; Radivoyevitch T; Przychodzen B; Sekeres MA; Levine RL; Maciejewski JP
Blood; 2014 Sep; 124(11):1790-8. PubMed ID: 25006131
[TBL] [Abstract][Full Text] [Related]
5. Recurrent mutations in multiple components of the cohesin complex in myeloid neoplasms.
Kon A; Shih LY; Minamino M; Sanada M; Shiraishi Y; Nagata Y; Yoshida K; Okuno Y; Bando M; Nakato R; Ishikawa S; Sato-Otsubo A; Nagae G; Nishimoto A; Haferlach C; Nowak D; Sato Y; Alpermann T; Nagasaki M; Shimamura T; Tanaka H; Chiba K; Yamamoto R; Yamaguchi T; Otsu M; Obara N; Sakata-Yanagimoto M; Nakamaki T; Ishiyama K; Nolte F; Hofmann WK; Miyawaki S; Chiba S; Mori H; Nakauchi H; Koeffler HP; Aburatani H; Haferlach T; Shirahige K; Miyano S; Ogawa S
Nat Genet; 2013 Oct; 45(10):1232-7. PubMed ID: 23955599
[TBL] [Abstract][Full Text] [Related]
6.
Laczko D; Poveda-Rogers C; Matthews AH; Snaith O; Luger S; Bagg A; Caponetti GC; Morrissette JJD; Yang G
Leuk Lymphoma; 2024 Mar; ():1-7. PubMed ID: 38506144
[TBL] [Abstract][Full Text] [Related]
7. Cohesin gene mutations in tumorigenesis: from discovery to clinical significance.
Solomon DA; Kim JS; Waldman T
BMB Rep; 2014 Jun; 47(6):299-310. PubMed ID: 24856830
[TBL] [Abstract][Full Text] [Related]
8. Clinical and genomic characterization of patients diagnosed with the provisional entity acute myeloid leukemia with BCR-ABL1, a Swedish population-based study.
Orsmark-Pietras C; Landberg N; Lorenz F; Uggla B; Höglund M; Lehmann S; Derolf Å; Deneberg S; Antunovic P; Cammenga J; Möllgård L; Wennström L; Lilljebjörn H; Rissler M; Fioretos T; Lazarevic VL
Genes Chromosomes Cancer; 2021 Jun; 60(6):426-433. PubMed ID: 33433047
[TBL] [Abstract][Full Text] [Related]
9. RUNX1 mutations in acute myeloid leukemia are associated with distinct clinico-pathologic and genetic features.
Gaidzik VI; Teleanu V; Papaemmanuil E; Weber D; Paschka P; Hahn J; Wallrabenstein T; Kolbinger B; Köhne CH; Horst HA; Brossart P; Held G; Kündgen A; Ringhoffer M; Götze K; Rummel M; Gerstung M; Campbell P; Kraus JM; Kestler HA; Thol F; Heuser M; Schlegelberger B; Ganser A; Bullinger L; Schlenk RF; Döhner K; Döhner H
Leukemia; 2016 Nov; 30(11):2160-2168. PubMed ID: 27137476
[TBL] [Abstract][Full Text] [Related]
10. Whole Exome Sequencing Identifies Cohesin Component STAG1 Mutation in de novo Acute Myeloid Leukemia (FAB M2): A Pilot Study with Cytogenetics, Clinical and Prognostic Implications.
Sakthivel KM; Geetha N; Raj TVA; Chandran RK; Krishna KMNJ; Sreedharan H
J Environ Pathol Toxicol Oncol; 2021; 40(1):51-64. PubMed ID: 33639073
[TBL] [Abstract][Full Text] [Related]
11. Whole-exome sequencing reveals the spectrum of gene mutations and the clonal evolution patterns in paediatric acute myeloid leukaemia.
Shiba N; Yoshida K; Shiraishi Y; Okuno Y; Yamato G; Hara Y; Nagata Y; Chiba K; Tanaka H; Terui K; Kato M; Park MJ; Ohki K; Shimada A; Takita J; Tomizawa D; Kudo K; Arakawa H; Adachi S; Taga T; Tawa A; Ito E; Horibe K; Sanada M; Miyano S; Ogawa S; Hayashi Y
Br J Haematol; 2016 Nov; 175(3):476-489. PubMed ID: 27470916
[TBL] [Abstract][Full Text] [Related]
12. [Molecular pathogenesis of myelodysplastic syndromes with concurrent mutations in cohesin STAG2 and transcription factor RUNX1].
Ochi Y
Rinsho Ketsueki; 2021; 62(5):352-359. PubMed ID: 34108313
[TBL] [Abstract][Full Text] [Related]
13. Integrated genomic-metabolic classification of acute myeloid leukemia defines a subgroup with NPM1 and cohesin/DNA damage mutations.
Simonetti G; Mengucci C; Padella A; Fonzi E; Picone G; Delpino C; Nanni J; De Tommaso R; Franchini E; Papayannidis C; Marconi G; Pazzaglia M; Perricone M; Scarpi E; Fontana MC; Bruno S; Tebaldi M; Ferrari A; Bochicchio MT; Ghelli Luserna Di Rorà A; Ghetti M; Napolitano R; Astolfi A; Baldazzi C; Guadagnuolo V; Ottaviani E; Iacobucci I; Cavo M; Castellani G; Haferlach T; Remondini D; Capozzi F; Martinelli G
Leukemia; 2021 Oct; 35(10):2813-2826. PubMed ID: 34193978
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive genomic profiling reveals molecular subsets of
Johnson SM; Haberberger J; Galeotti J; Ramkissoon L; Coombs CC; Richardson DR; Foster MC; Duncan D; Montgomery ND; Ferguson NL; Zeidner JF
Leuk Lymphoma; 2024 Feb; 65(2):209-218. PubMed ID: 37921062
[TBL] [Abstract][Full Text] [Related]
15. Cohesin mutations in human cancer.
Hill VK; Kim JS; Waldman T
Biochim Biophys Acta; 2016 Aug; 1866(1):1-11. PubMed ID: 27207471
[TBL] [Abstract][Full Text] [Related]
16. Comparison of mutational profiles and clinical outcomes in patients with acute myeloid leukemia with mutated
Nguyen L; Zhang X; Roberts E; Yun S; McGraw K; Abraham I; Song J; Braswell D; Qin D; Sallman DA; Lancet JE; List AF; Moscinski LC; Padron E; Zhang L
Leuk Lymphoma; 2020 Jun; 61(6):1395-1405. PubMed ID: 32091281
[TBL] [Abstract][Full Text] [Related]
17. Integrative study of EZH2 mutational status, copy number, protein expression and H3K27 trimethylation in AML/MDS patients.
Stomper J; Meier R; Ma T; Pfeifer D; Ihorst G; Blagitko-Dorfs N; Greve G; Zimmer D; Platzbecker U; Hagemeijer A; Schmitt-Graeff I; Lübbert M
Clin Epigenetics; 2021 Apr; 13(1):77. PubMed ID: 33845873
[TBL] [Abstract][Full Text] [Related]
18. Morphologic, immunophenotypic, molecular genetic, and clinical characterization in patients with SRSF2-mutated acute myeloid leukemia.
Tatarian J; Tupper N; Li P; Feusier J; Abdo M; Hyter S; Gonzales PR; Zhang D; Woodroof J; Kelting S; Godwin AK; Cui W
Am J Clin Pathol; 2023 Nov; 160(5):490-499. PubMed ID: 37458189
[TBL] [Abstract][Full Text] [Related]
19. A cohesive look at leukemogenesis: The cohesin complex and other driving mutations in AML.
Heimbruch KE; Meyer AE; Agrawal P; Viny AD; Rao S
Neoplasia; 2021 Mar; 23(3):337-347. PubMed ID: 33621854
[TBL] [Abstract][Full Text] [Related]
20. NPM1-mutated AML-MRC diagnosed on the basis of history of MDS or MDS/MPN frequently harbours secondary-type mutations and confers inferior outcome compared to AML with mutated NPM1.
Zhao D; Zarif M; Eladl E; Capo-Chichi JM; Smith AC; Atenafu EG; Tierens A; Minden MD; Schuh A; Chang H
Leuk Res; 2022 Jul; 118():106869. PubMed ID: 35636054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
